EVLO - Evelo Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EVLO is currently covered by 3 analysts with an average price target of $1.27. This is a potential upside of $1.27 (0%) from yesterday's end of day stock price of $0.

Evelo Biosciences's activity chart (see below) currently has 15 price targets and 15 ratings on display. The stock rating distribution of EVLO is 60% BUY and 40% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 76.19% with an average time for these price targets to be met of 85.29 days.

Highest price target for EVLO is $55, Lowest price target is $7, average price target is $1.27.

Most recent stock forecast was given by VIKRAM PUROHIT from MORGAN STANLEY on 26-Jul-2023. First documented stock forecast 04-Jun-2018.

Currently out of the existing stock ratings of EVLO, 3 are a BUY (60%), 2 are a HOLD (40%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$2

$1.95 (3900.00%)

$80

1 years 3 months 28 days ago
(26-Jul-2023)

1/2 (50%)

$-5.88 (-74.62%)

83

Buy

$10

$9.96 (24900.00%)

$10

1 years 8 months 6 days ago
(17-Mar-2023)

2/2 (100%)

$4.82 (93.05%)

79

Buy

$5

$4.96 (12400.00%)

1 years 8 months 7 days ago
(16-Mar-2023)

1/1 (100%)

$-0.98 (-16.39%)

4

Buy

$280

1 years 9 months 22 days ago
(01-Feb-2023)

1/3 (33.33%)

$120.6 (75.66%)

6

Buy

$50

$49.95 (99900.00%)

$12

2 years 7 days ago
(16-Nov-2022)

3/4 (75%)

$4.2 (9.17%)

100

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EVLO (Evelo Biosciences) average time for price targets to be met?

On average it took 85.29 days on average for the stock forecasts to be realized with a an average price target met ratio 76.19

Which analyst has the current highest performing score on EVLO (Evelo Biosciences) with a proven track record?

KEAY NAKAE

Which analyst has the current lower performing score on EVLO (Evelo Biosciences) with a proven track record?

GARY NACHMAN

Which analyst has the most public recommendations on EVLO (Evelo Biosciences)?

Keay Nakae works at CHARDAN CAPITAL and has 2 price targets and 6 ratings on EVLO

Which analyst is the currently most bullish on EVLO (Evelo Biosciences)?

Matthew Harrison with highest potential upside - $259.95

Which analyst is the currently most reserved on EVLO (Evelo Biosciences)?

Chris Howerton with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?